Diagnosis and Treatment of Optic Neuritis with Negative Infectious Disease Tests and Family History of Psychosis
The most likely diagnosis is optic neuritis requiring immediate treatment with high-dose intravenous methylprednisolone (1000 mg daily for 3 days), followed by an oral prednisone taper to prevent vision loss and improve outcomes.
Diagnostic Approach
Clinical Evaluation
- Optic neuritis presents with the classic triad of:
- Visual loss (can be unilateral or bilateral)
- Periocular pain (especially with eye movement)
- Dyschromatopsia (color vision impairment) 1
- Fundoscopic examination may reveal papilledema/papillitis/optic disc swelling in acute cases 2
- Assess for neurological symptoms that might suggest demyelinating disease
Imaging Studies
- MRI of orbits and brain with and without contrast is the primary imaging study for initial assessment of suspected optic neuritis 3
- Evaluates for abnormal enhancement and signal changes within the optic nerve
- Assesses for intracranial demyelinating lesions that predict development of multiple sclerosis
- T1-weighted post-contrast images with fat suppression identify abnormal enhancement in 95% of cases 2
- Coronal images with fat suppression and T2 sequences with submillimetric resolution are recommended 2
Laboratory Testing
- Serum testing for:
- CSF analysis to check for:
- Oligoclonal bands (common in MS-related optic neuritis)
- Pleocytosis (neutrophilic pleocytosis or WCC > 50/μl suggests MOG-IgG associated disorder) 3
Differential Diagnosis
The negative infectious disease tests (including Lyme disease) and family history of psychosis require careful consideration of several potential diagnoses:
Multiple Sclerosis (MS)-associated optic neuritis
- Most common cause of demyelinating optic neuritis 1
- Brain MRI may show periventricular white matter lesions
Neuromyelitis Optica Spectrum Disorders (NMOSD)
MOG-IgG Associated Disorder
Idiopathic Optic Neuritis
Autoimmune-Related Optic Neuritis
- Family history of autoimmune conditions (like psychosis potentially associated with autoimmune encephalitis) may be relevant
Treatment Algorithm
Acute Treatment
First-line therapy: Intravenous methylprednisolone
- Dose: 1000 mg daily for 3 days 2, 6
- Followed by oral prednisone taper 2
- Initiate as early as possible, ideally within the first few hours of symptom onset 2
- IMPORTANT: Oral prednisone alone (without prior IV methylprednisolone) at 1 mg/kg/day should be avoided as it may increase risk of recurrent optic neuritis 2
For steroid-refractory cases:
Long-term Management
- Based on the underlying etiology:
- If MS is diagnosed: Consider disease-modifying therapies like interferon β-1a,b which have been shown to reduce risk of MS progression 1
- If NMOSD is diagnosed: Consider rituximab as first-line therapy, particularly for patients with severe disease 2
- If MOG-IgG positive: Consider immunosuppressive therapy with rituximab, azathioprine, or mycophenolate mofetil 2
Monitoring and Follow-up
- Monitor visual acuity, color vision, contrast sensitivity, and visual fields
- These parameters may remain impaired even after good recovery of visual acuity 1
- Regular MRI follow-up may be needed to monitor for development of MS or other demyelinating disorders
- Screen for hepatitis B infection before initiating immunosuppressive treatment 6
Important Precautions
- Live or attenuated vaccines are contraindicated during immunosuppressive corticosteroid therapy 6
- High-dose IV methylprednisolone can rarely cause toxic hepatitis; discontinue if this occurs 6
- Avoid corticosteroids in patients with active ocular herpes simplex, systemic fungal infections, or cerebral malaria 2, 6
- Monitor for steroid-related complications including hyperglycemia, hypertension, and mood changes 6
Clinical Pearls
- The family history of psychosis should not delay treatment of optic neuritis but may warrant additional neuropsychiatric evaluation
- The pulmonary fibrosis in family history is likely unrelated to optic neuritis but should be noted
- Visual outcomes are generally better with prompt treatment, highlighting the importance of early diagnosis and intervention 7
- Relapses are common (50-60%) during corticosteroid dose reduction, highlighting the need for careful tapering and potential maintenance therapy 2